NEWS: Med-Device Startup Enables Doctors to be Reimbursed for its Noninvasive Microvascular Assessment Technology
A med-device startup has been granted a new CPT code so doctors can be reimbursed when they use its tech.
Modulim‘s tech captures, analyzes and reports micovascular activity in patients at risk for compromised circulation.
It does this through a device – the Clarifi Imaging System, which assesses tissue oxygen and perfusion in patients with compromised circulation (patients with peripheral artery disease, slow-healing wounds or diabetic foot problems, for example).
Modulim, formerly known as Modulated Imaging, close a $7 million Series B round earlier this year. See related story here.
CPT codes are granted and maintained by the American Medical Association and are widely used by government payers, including Medicare and Medicaid, as well as commercial health plans to describe healthcare services and procedures for reimbursement.
Modulim is one of the pioneers of sub-surface optical imaging, an advanced imaging technique co-invented by founding CEO and CTO David Cuccia.
It’s a non-nvasive tissue oxygen saturation technology that combines structured illumination with multiple wavelengths of light (visible and near-infrared) to allow for deeper and layer-specific assessment of tissue oxygenation and hemoglobin.